The HGF mimic compositions (preparations) of the present invention may be administered by any of the many suitable means which are well known to those of skill in the art, including but not limited to: by injection, inhalation, orally, intra vaginally, intranasally, by ingestion of a food or product containing the mimic, topically, as eye drops, via sprays, etc
In research contexts, investigators typically define model-specific controls, endpoints (for example, scratch-wound assay closure metrics, transwell migration, TEER and barrier-integrity markers, cytokine panels, ECM-related markers), and time points
Retrieved February 10, 2019
Mechanism map How BPC-157 / TB-500 Blend is positioned Our most popular blend combines BPC-157 and TB-500 in optimized ratios for thorough tissue repair
Gastrointestinal adverse events were common (79.6% vs